流量转换器对分支结合的动脉瘤的长期结果
Hyun Jin Han1, Byung Moon Kim1, Keun Young Park1
1From the Department of Neurosurgery (H.J.H., K.Y.P., Y.B.K., K.S.C., S.K.), Department of Radiology (B.M.K., D.J.K., K.S.C., S.K.), Severance Hospital, Yonsei University College of Medicine; Department of Radiology (J.H.K.), Department of Neurosurgery (C.K.J.), Yongin Severance Hospital, Yonsei University College of Medicine; Department of Neurosurgery (S.Y.), Hallym University Dongtan Sacred Heart Hospital; Department of Neurosurgery (M.J.K.), Uijeongbu St. Mary's Hospital, The Catholic University of Korea College of Medicine; Department of Neurosurgery (J.K.L.), Gangnam Severance Hospital, Yonsei University College of Medicine; Department of Neurosurgery (S.K.), Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea.
支部内置动脉瘤的流量转移器 (FD) 治疗显示短期阻塞率较低,但长期比较的比率. 虽然一些合并的分支被堵塞了,但没有发生永久的神经缺陷,这表明安全性.
科学领域:
- 神经学 神经学
- 干预性神经辐射学
- 血管外科 血管外科
背景情况:
- 对于用流量转移器 (FD) 治疗的分支结合性动脉瘤的长期结果的理解有限.
- 需要关于FD在这种特定动脉瘤亚型中的疗效和安全性的数据.
研究的目的:
- 评估分支结合性动脉瘤的流量转移的长期临床和血管学结果.
- 为了评估FD处理后的遮率和分支通透度.
主要方法:
- 来自五个韩国中心的前性维护数据库的回顾性分析.
- 包括那些接受了FD安置的患者,因为没有破裂的动脉瘤与内置的分支动脉.
- 评估长期临床 (mRS分数) 和血管检查结果 (动脉瘤闭塞,分支通透性).
主要成果:
- 分析了65名患有动脉瘤 (中位数为11.1毫米) 的患者.
- 在63名患者中观察到高水平的有利结局 (mRS 0-1).
- >48个月的长期动脉瘤闭塞率达到86.5%;在40%的病例中,合并的分支仍然是专利.
结论:
- 对分支结合性动脉瘤的流量转移显示,最初的阻塞率较低,但长期疗效与文献相比较.
- 虽然23%的注册分支机构被封闭,但这并没有导致永久的神经缺陷.
- FD是一种安全有效的选择,用于管理分支结合性动脉瘤,具有良好的长期效果.
相关概念视频
Long-term Depression
Long-term Depression
Calcium Ion Concentration Mechanism
If over...
Predicting Reaction Outcomes
Outcomes of Glycolysis
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...
Aneurysm I: Introduction
Guidelines for Writing Outcome
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...


